DECISION SUPPORT SYSTEM (DSS) FOR MOLECULAR RADIOTHERAPY BASED ON DIGITAL PATIENTS (Q2035310): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed label, description and/or aliases in 2 languages: Changing unique label-description pair)
(‎Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement)
Property / financed by
 
Property / financed by: Directorate-General for Regional and Urban Policy / rank
Normal rank
 

Revision as of 08:41, 2 November 2020

Project Q2035310 in Italy
Language Label Description Also known as
English
DECISION SUPPORT SYSTEM (DSS) FOR MOLECULAR RADIOTHERAPY BASED ON DIGITAL PATIENTS
Project Q2035310 in Italy

    Statements

    0 references
    183,393.18 Euro
    0 references
    366,786.35 Euro
    0 references
    50.0 percent
    0 references
    13 December 2016
    0 references
    6 July 2019
    0 references
    UNIVERSITA' DEGLI STUDI DI ROMA LA SAPIENZA
    0 references
    KAY SYSTEMS ITALIA SRL
    0 references
    0 references
    0 references
    0 references

    41°53'35.95"N, 12°28'58.55"E
    0 references
    LA RADIOTERAPIA MOLECOLARE, INDICATA IN MOLTE NEOPLASIE, IMPIEGA RADIONUCLIDI COME SORGENTI NON SIGILLATE (SPESSO RADIOFARMACI) PER RILASCIARE RADIAZIONI E DISTRUGGERE CELLULE NEOPLASTICHE. (Italian)
    0 references
    THE MOLECULAR RADIOTHERAPY, REFERRED TO IN MANY CANCERS, USES RADIONUCLIDES AS NON-SEALED SOURCES (OFTEN RADIOPHARMACEUTICALS) TO RELEASE RADIATION AND DESTROY NEOPLASTIC CELLS. (English)
    0 references

    Identifiers

    F87H18000440007
    0 references